Crestline Management’s Denali Therapeutics DNLI Stock Holding History

Crestline Management’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.4M	Sell	2,210,732 -600,000	-21%	-$11.9M	91.74%	1
2025 Q4	$46.4M	Sell	2,810,732 -600,000	-18%	-$10.1M	87.02%	1
2025 Q3	$49.5M	Sell	3,410,732 -450,000	-12%	-$6.47M	85.26%	1
2025 Q2	$54M	Sell	3,860,732 -300,000	-7%	-$4.22M	86.33%	1
2025 Q1	$56.6M	Sell	4,160,732 -150,000	-3%	-$2.87M	89.45%	1
2024 Q4	$87.9M	Sell	4,310,732 -150,000	-3%	-$3.84M	3.06%	3
2024 Q3	$130M	Sell	4,460,732 -300,000	-6%	-$7.44M	7.4%	3
2024 Q2	$111M	Sell	4,760,732 -450,000	-9%	-$8.64M	8.67%	2
2024 Q1	$107M	Sell	5,210,732 -450,000	-8%	-$8.46M	10.12%	1
2023 Q4	$121M	Sell	5,660,732 -300,000	-5%	-$5.94M	11.25%	1
2023 Q3	$123M	Sell	5,960,732 -150,000	-2%	-$3.8M	14.69%	1
2023 Q2	$180M	Sell	6,110,732 -300,000	-5%	-$8.44M	19.62%	1
2023 Q1	$148M	Sell	6,410,732 -450,000	-7%	-$12.4M	18.05%	1
2022 Q4	$191M	Sell	6,860,732 -300,000	-4%	-$8.93M	27.96%	1
2022 Q3	$220M	Sell	7,160,732 -300,000	-4%	-$9.75M	29.71%	1
2022 Q2	$220M	Hold	7,460,732	–	–	28.78%	1
2022 Q1	$240M	Sell	7,460,732 -244,307	-3%	-$8.41M	30.17%	1
2021 Q4	$344M	Hold	7,705,039	–	–	25.82%	1
2021 Q3	$389M	Sell	7,705,039 -430,442	-5%	-$24.3M	36.97%	1
2021 Q2	$638M	Sell	8,135,481 -1,849,355	-19%	-$114M	55.19%	1
2021 Q1	$570M	Sell	9,984,836 -9,477,664	-49%	-$634M	73.16%	1
2020 Q4	$339M	Buy	19,462,500 +7,260,866	+60%	+$439M	37.52%	1
2020 Q3	$437M	Sell	12,201,634 -1,443,247	-11%	-$43.5M	67.95%	1
2020 Q2	$330M	Sell	13,644,881 -1,922,855	-12%	-$45.2M	75.17%	1
2020 Q1	$273M	Sell	15,567,736 -3,894,764	-20%	-$81.2M	78.45%	1
2019 Q4	$339M	Hold	19,462,500	–	–	43.9%	1
2019 Q3	$298M	Hold	19,462,500	–	–	48.02%	1
2019 Q2	$404M	Hold	19,462,500	–	–	54.41%	1
2019 Q1	$452M	Hold	19,462,500	–	–	98.01%	1
2018 Q4	$402M	Sell	19,462,500 -1,111,799	-5%	-$20.2M	60.8%	1
2018 Q3	$447M	Hold	20,574,299	–	–	41.41%	1
2018 Q2	$314M	Hold	20,574,299	–	–	32.97%	1
2018 Q1	$405M	Buy	20,574,299 +1	+0%	+$21	50.4%	1
2017 Q4	$322M	Buy	+20,574,298	New	+$370M	32.96%	2